Diagnostic Values of Laboratory Biomarkers in Predicting a Severe Course of COVID-19 on Hospital Admission

• Published in: BioMed research international Vol. 2022; pp. 5644956 - 11
• Main Authors: Tummala, Anusha, Ramesh, Venkat, Balakrishna, Nagalla, Koyyada, Rajeswari, Singh, Anula Divyash, Patnam, Sreekanth, Satish Kumar, M., Varahala, Sneha, Manda, Sasidhar V., Narreddy, Suneetha
• Format: Journal Article
• Language: English
• Published: United States Hindawi 07.11.2022; John Wiley & Sons, Inc; Hindawi Limited
• Subjects: Admission and discharge; Alanine; Albumin; Albumins; Aspartate aminotransferase; Biological markers; Biomarkers; Blood; Blood platelets; Cardiovascular disease; Comorbidity; Coronaviruses; COVID-19; COVID-19 - diagnosis; COVID-19 Testing; Creatinine; Diabetes; Diagnosis; Eosinophils; Ferritin; Fever; Gender; Globulins; Hematology; Hospitals; Humans; Hypertension; Inflammation; Interleukin 6; L-Lactate dehydrogenase; Laboratories; Lactate dehydrogenase; Lactic acid; Leukocytes (eosinophilic); Leukocytes (neutrophilic); Lymphocytes; Medical examination; Medical research; Medicine, Experimental; Monocytes; Neutrophils; Patients; Prognosis; Prothrombin; Regression analysis; Regression models; Retrospective Studies; Statistical analysis; Urea; Ureas; Variables; Viral diseases; India

Objective. We intend to identify differences in the clinicodemographic and laboratory findings of COVID-19 patients to predict disease severity and outcome on admission. Methods. This single-centred retrospective study retrieved laboratory and clinical data from 350 COVID-19 patients on admission, r...